Study Details

Back
Study ID 3550-CL-0002
Study Title An open-label, multi-centre, extension study investigating the long-term safety of repeated doses of FE200486 given as subcutaneous injections to prostate cancer patients
Clinicaltrials.gov Identifier Not Applicable
Compound Name ASP3550 / degarelix acetate
Medical Indication or Disease Prostate cancer
Study Sponsor Astellas Pharma Inc.
Collaborator Not Applicable
Study Start Date 09-May-2005
Study Completion Date 23-Jun-2010
Clinical Study Result
Select the language
English
Plain Language Summary
Select the language
Not Available

QUICK SEARCH

USEFUL LINKS